Vaccination Recommendations in Patients With Atopic Dermatitis Treated With Inhibitors
Ara-Martín, Mariano (Instituto de Investigación Sanitaria de Aragón)
Moreno, Carol (Hospital Universitario de Getafe (Madrid))
Ruíz Villaverde, Ricardo (Instituto Biosanitario de Granada, Ibs)
Serra Baldrich, Esther (Institut de Recerca Sant Pau)
Hernández-Martín, Irene (Pfizer)
del Pilar Fortes, Maria (Pfizer)
Universitat Autònoma de Barcelona. Departament de Medicina

Date:	2025
Abstract:	Atopic dermatitis therapy has undergone a revolutionary change with the introduction of Janus kinase (JAK) inhibitors. Despite their general safety profile, these immunomodulatory drugs require special precautions with respect to infection risk and vaccine administration. This document aims to provide dermatologists and other healthcare practitioners with comprehensive practical vaccination recommendations for adults and adolescent patients with atopic dermatitis who are receiving or are about to receive treatment with JAK inhibitors. While inactivated vaccines are safe and recommended during JAK treatment, live attenuated vaccines are contraindicated unless treatment is temporarily discontinued according to clinical guidelines. It is crucial to follow vaccination guidelines established by official agencies and tailor them to individual patient needs. Careful consideration and follow-up are essential to ensure patient safety and optimal therapeutic outcomes. Inmunization and Screening Protocol for the Safe Initiation of JAK Inhibitors.
Rights:	Aquest document està subjecte a una llicència d'ús Creative Commons. Es permet la reproducció total o parcial, la distribució, i la comunicació pública de l'obra, sempre que no sigui amb finalitats comercials, i sempre que es reconegui l'autoria de l'obra original. No es permet la creació d'obres derivades.
Language:	Anglès
Document:	Article ; recerca ; Versió publicada
Subject:	Atopic dermatitis ; JAK inhibitors ; Recommendations ; Vaccination
Published in:	International Journal of Dermatology, Vol. 65 (September 2025) , p. 230-237, ISSN 1365-4632

DOI: 10.1111/ijd.70033
PMID: 40928003

8 p, 315.6 KB

The record appears in these collections:
Research literature > UAB research groups literature > Research Centres and Groups (research output) > Health sciences and biosciences > Institut de Recerca Sant Pau
Articles > Research articles
Articles > Published articles